We are live on ! Find out more
LOAMS

Lombard Odier Asset Management (Switzerland) Portfolio holdings

AUM $2.63B
1-Year Est. Return 31.52%
This Fund
S&P 500
This Quarter Est. Return
+9.01%
1 Year Est. Return
+31.52%
3 Year Est. Return
+98.77%
5 Year Est. Return
+107.98%
10 Year Est. Return
+494.97%
AUM
$1.97B
AUM Growth
+$464M
Cap. Flow
+$324M
Cap. Flow %
16.44%
Top 10 Hldgs %
16.43%
Holding
517
New
127
Increased
265
Reduced
66
Closed
22

Top Buys

Rank Stock Value
1
AMP icon
Ameriprise Financial
AMP
+$25.4M
2
BIIB icon
Biogen
BIIB
+$22.8M
3
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
+$21.9M
4
INMD icon
InMode
INMD
+$21.2M
5
BNTX icon
BioNTech
BNTX
+$17.7M

Top Sells

Rank Stock Value
1
FUTU icon
Futu Holdings
FUTU
+$23.2M
2
MRNA icon
Moderna
MRNA
+$22.4M
3
SCHW
Charles Schwab
SCHW
+$17.5M
4
NUAN
Nuance Communications, Inc.
NUAN
+$10.5M
5
NTLA icon
Intellia Therapeutics
NTLA
+$9.95M

Sector Composition

Rank Sector Weight
1 Healthcare 50.23%
2 Consumer Discretionary 12.76%
3 Financials 9.78%
4 Technology 6.11%
5 Industrials 3.67%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
GDRX icon
1
GoodRx Holdings
GDRX
$1.29B
$40.7M 2.06%
1,129,083
+364,304
+48% +$13.4M
EXAS
2
DELISTED
Exact Sciences
EXAS
$34.4M 1.75%
276,921
+62,311
+29% +$7.44M
AXP icon
3
American Express
AXP
$228B
$34.4M 1.74%
208,021
-24,598
-11% -$3.85M
IQV icon
4
IQVIA
IQV
$39.9B
$32.4M 1.64%
133,563
+11,875
+10% +$2.74M
TMO icon
5
Thermo Fisher Scientific
TMO
$220B
$31.9M 1.62%
63,220
-4,065
-6% -$1.92M
KEYS icon
6
Keysight
KEYS
$58.3B
$31.6M 1.6%
204,655
+517
+0.3% +$75K
LOW icon
7
Lowe's Companies
LOW
$123B
$30.3M 1.53%
155,976
-25,399
-14% -$4.97M
TNDM icon
8
Tandem Diabetes Care
TNDM
$1.57B
$30.1M 1.53%
309,447
+81,116
+36% +$7.23M
UNH icon
9
UnitedHealth
UNH
$372B
$29.2M 1.48%
72,873
+22,072
+43% +$8.8M
MRK icon
10
Merck
MRK
$322B
$29.1M 1.48%
374,559
+41,498
+12% +$3.09M
ELS icon
11
Equity Lifestyle Properties
ELS
$12.5B
$28.2M 1.43%
380,000
+110,000
+41% +$7.78M
LH icon
12
Labcorp
LH
$25.9B
$27.9M 1.41%
117,526
+11,731
+11% +$2.67M
ABT icon
13
Abbott
ABT
$188B
$27.2M 1.38%
234,614
+37,194
+19% +$4.34M
ABBV icon
14
AbbVie
ABBV
$434B
$27.2M 1.38%
241,139
+28,310
+13% +$3.19M
HOLX
15
DELISTED
Hologic
HOLX
$27.1M 1.38%
406,358
+3,217
+0.8% +$215K
LHCG
16
DELISTED
LHC Group LLC
LHCG
$27M 1.37%
135,000
+25,000
+23% +$5.01M
SCI icon
17
Service Corp International
SCI
$11.4B
$26.8M 1.36%
500,000
– –
BIIB icon
18
Biogen
BIIB
$30.5B
$26.7M 1.35%
77,129
+75,362
+4,265% +$22.8M
V icon
19
Visa
V
$671B
$26.6M 1.35%
113,583
-6,795
-6% -$1.55M
NTRA icon
20
Natera
NTRA
$45.8B
$26.5M 1.34%
233,468
+70,190
+43% +$7.18M
BHVN
21
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
$26.2M 1.33%
+270,358
New +$21.9M
TWST icon
22
Twist Bioscience
TWST
$7.78B
$26.2M 1.33%
196,676
+89,273
+83% +$10.4M
PHM icon
23
Pultegroup
PHM
$24.7B
$26M 1.32%
476,499
-24,125
-5% -$1.35M
NEO icon
24
NeoGenomics
NEO
$2.12B
$25.6M 1.3%
566,461
+203,619
+56% +$9.02M
AMP icon
25
Ameriprise Financial
AMP
$49.3B
$25.4M 1.29%
102,159
+100,918
+8,132% +$25.4M
1
2 3 4 5

Similar funds

SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
WWM
Western Wealth Management Golden, Colorado $2.63B AUM 21.3% 1-Year Est. Return
ACM
Advance Capital Management Southfield, Michigan $2.64B AUM 13.57% 1-Year Est. Return
WCA
Waratah Capital Advisors Toronto, Ontario, Canada $2.63B AUM 76.33% 1-Year Est. Return
NIG
NFJ Investment Group Dallas, Texas $2.64B AUM 23.86% 1-Year Est. Return
CCM
Cerberus Capital Management New York $2.65B AUM 20.18% 1-Year Est. Return
HI
Helikon Investments London, United Kingdom $2.65B AUM 79.03% 1-Year Est. Return
MG
Meritage Group San Francisco, California $2.65B AUM 6.3% 1-Year Est. Return

Lombard Odier Asset Management (Switzerland)'s Q2 2021 Portfolio in Review

As of Q2 2021, Lombard Odier Asset Management (Switzerland) held 517 positions worth $1.97B, up 31% from $1.51B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Lombard Odier Asset Management (Switzerland) deployed $324M of net new capital in Q2 2021, opening 127 new positions and adding to 265 existing holdings. Its largest new stake was Biohaven Pharmaceutical Holding Company Ltd.: 270,358 shares worth $26.2M.

By sector, the portfolio is most concentrated in Healthcare at 50% of assets, up from 45% a quarter earlier, followed by Consumer Discretionary and Financials.

On the sell side, the largest reduction was Moderna, an estimated $22.4M trimmed.

  • Lombard Odier Asset Management (Switzerland)'s largest Q2 2021 buy was Biohaven Pharmaceutical Holding Company Ltd.: 270,358 shares worth $26.2M.
  • Lombard Odier Asset Management (Switzerland) added most to Ameriprise Financial in Q2 2021, an estimated $25.4M increase.
  • Lombard Odier Asset Management (Switzerland)'s biggest Q2 2021 reduction was Moderna, cutting an estimated $22.4M.
  • Lombard Odier Asset Management (Switzerland) fully exited Futu Holdings in Q2 2021, selling an estimated $23.2M.
  • Lombard Odier Asset Management (Switzerland)'s ten largest holdings make up 16% of its $1.97B portfolio in Q2 2021.
  • Lombard Odier Asset Management (Switzerland) opened 127 new positions and closed 22 in Q2 2021.
  • Lombard Odier Asset Management (Switzerland)'s portfolio value rose 31% quarter-over-quarter to $1.97B.

Based on Lombard Odier Asset Management (Switzerland)'s 13F filing for Q2 2021, filed 13 Aug 2021.